Ado-trastuzumab emtansine and NovoLog FlexPen
Determining the interaction of Ado-trastuzumab emtansine and NovoLog FlexPen and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-Trastuzumab Emtansine
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine-Novolog Injection
- Ado-trastuzumab emtansine-NovoLog Mix 70/30
- Ado-trastuzumab emtansine-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens))
- Ado-trastuzumab emtansine-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Vials))
- Ado-trastuzumab emtansine-NovoLog Mix 70/30 FlexPen
- Ado-trastuzumab emtansine-NovoLog PenFill
- NovoLog FlexPen-Ado-trastuzumab emtansine Intravenous
- NovoLog FlexPen-Adox Pak 2/100
- NovoLog FlexPen-Adoxa
- NovoLog FlexPen-Adoxa CK
- NovoLog FlexPen-Adoxa Pak
- NovoLog FlexPen-Adoxa Pak 1/100